Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Jan;66(1):92-6.
doi: 10.1001/archneurol.2008.521.

Olfactory function in corticobasal syndrome and frontotemporal dementia

Matteo Pardini  1 , Edward D Huey, Alyson L Cavanagh, Jordan Grafman
Affiliations

Olfactory function in corticobasal syndrome and frontotemporal dementia

Matteo Pardini et al. Arch Neurol. 2009 Jan.

Abstract

Background: Formal olfactory testing may be useful as a bedside tool to help differentiate between conditions such as atypical parkinsonism, dementia, and psychiatric conditions. However, the neural basis of olfactory dysfunction, the effect of concurrent cognitive deficits on olfactory testing results, and the exact prevalence of olfactory deficits in populations with corticobasal syndrome (CBS) and the frontal variant of frontotemporal dementia (FTD-FV) are to date unclear.

Objective: To assess the prevalence and the neural basis of olfactory recognition deficits in patients with a clinical diagnosis of CBS or FTD-FV.

Design: Retrospective study of clinical, neuropsychological, and imaging data.

Setting: National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland.

Participants: Twenty-five patients with CBS, 22 with FTD-FV, and 12 age-matched control subjects.

Main outcome measures: Results of neuropsychological evaluation, formal olfactory recognition testing (University of Pennsylvania Smell Identification Test [UPSIT]), and voxel-based morphometry analysis of structural magnetic resonance images of the brain.

Results: Mean UPSIT percentile scores were 31.6% for the CBS group and 9.5% for the FTD-FV group. The voxel-based morphometry correlations between local gray matter and UPSIT scores showed a significant volume effect in the right midfrontal gyrus for the FTD-FV patients and in the right insula, right midfrontal gyrus, and bilateral inferior frontal gyrus for the patients with CBS. A linear regression analysis of the UPSIT scores revealed as significant predictors the general memory score of the Wechsler Memory Scale and the Boston Naming Test total score for the patients with FTD-FV and the Mattis Dementia Rating Scale total score for the patients with CBS.

Conclusions: Our data showed a more severe olfactory impairment for CBS patients than previously reported. We also showed a significant relationship between formal olfactory recognition testing scores and specific cognitive domains. These findings could be useful to clinically differentiate FTD-FV and CBS from other dementing illnesses and movement disorders.

PubMed Disclaimer

Figures

Figure
Figure
Local volume maxima of volume loss for the voxel-based morphometry analysis contrasts. Areas of local volume reduction in patients with the frontal variant of frontotemporal dementia (FTD-FV) (A) and corticobasal syndrome (CBS) (B) compared with control subjects. Local areas of correlation between local gray matter volume and University of Pennsylvania Smell Identification Test scores in patients with FTD-FV (C) and CBS (D). The statistical thresholds of the individual analysis are described in the “MRI Acquisition and Statistical Analysis” subsection of the “Methods” section.
See this image and copyright information in PMC

References

    1. Kovács T. Mechanisms of olfactory dysfunction in aging and neurodegenerative disorders. Ageing Res Rev. 2004;3(2):215–232. - PubMed
    1. Mesholam RI, Moberg PJ, Mahr RN, Doty RL. Olfaction in neurodegenerative disease: a meta-analysis of olfactory functioning in Alzheimer’s and Parkinson’s diseases. Arch Neurol. 1998;55(1):84–90. - PubMed
    1. Suchowersky O, Reich S, Perlmutter J, Zesiewicz T, Gronseth G, Weiner WJ Quality Standards Subcommittee of the American Academy of Neurology. Practice parameter: diagnosis and prognosis of new onset Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2006;66(7):968–975. - PubMed
    1. Doty RL, Deems DA, Stellar S. Olfactory dysfunction in parkinsonism: a general deficit unrelated to neurologic signs, disease stage, or disease duration. Neurology. 1988;38(8):1237–1244. - PubMed
    1. Luzzi S, Snowden JS, Neary D, Coccia M, Provinciali L, Lambon Ralph MA. Distinct patterns of olfactory impairment in Alzheimer’s disease, semantic dementia, frontotemporal dementia, and corticobasal degeneration. Neuropsychologia. 2007;45(8):1823–1831. - PubMed

Publication types

MeSH terms